A
엠아이텍
179290KOSDAQ72.3 / 100
Reference Date: 2026-09-08
Financial Score34.0 / 40
News Sentiment21.3 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and ROE significantly exceeds the industry average is also solid. Roughly flat over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
MITEC is a company that pioneered the development of non-vascular stents in South Korea, expanding its product portfolio and exporting to overseas markets. It obtained CE MDR certification in 2023 to enter the European market and is expanding its presence in the endoscopy sector by distributing Fujifilm endoscopy equipment.
Number of Employees
179people
Average Salary
52.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
8.13Industry Average 15.006.5Point
Lower than industry avg (good)
PBR
1.31Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
17.32Industry Average 8.007.0Point
2.2x industry avg (excellent)
Debt Ratio
5.27Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~202510.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲20.4% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲21.3% (2-year basis)
ROE Trend
4.0 / 4
Avg ROE 16.7% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85
- Positive"몸속 관 어디든 만든다"…日 시장 점유율 1위, 한국의 '스텐트 챔피...
엠아이텍의 혁신적인 비혈관 스텐트 기술로 일본 시장 점유율 1위 달성 및 글로벌 확장 계획 발표.
Detailed Momentum
52-week position3.0Point
52w lower range (25%)
Current 5,110Won52-week high 7,81052-week low 4,195
1-month return3.0Point
1m 0.59% (flat)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral반기보고서 (2026.06)2026-08-14